BUGATTI, Antonella
 Distribuzione geografica
Continente #
EU - Europa 3.570
NA - Nord America 3.528
AS - Asia 884
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
AF - Africa 2
SA - Sud America 2
Totale 7.998
Nazione #
US - Stati Uniti d'America 3.520
PL - Polonia 2.437
CN - Cina 514
UA - Ucraina 394
DE - Germania 198
IT - Italia 162
HK - Hong Kong 147
FI - Finlandia 129
VN - Vietnam 89
SG - Singapore 80
GB - Regno Unito 77
IE - Irlanda 72
FR - Francia 34
IN - India 26
CZ - Repubblica Ceca 18
SE - Svezia 11
BE - Belgio 10
RU - Federazione Russa 10
TR - Turchia 10
CA - Canada 7
EU - Europa 6
AU - Australia 5
ES - Italia 5
DK - Danimarca 3
NL - Olanda 3
AE - Emirati Arabi Uniti 2
EC - Ecuador 2
IR - Iran 2
KR - Corea 2
LK - Sri Lanka 2
MA - Marocco 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CY - Cipro 1
HU - Ungheria 1
IQ - Iraq 1
IS - Islanda 1
JO - Giordania 1
JP - Giappone 1
KZ - Kazakistan 1
MD - Moldavia 1
PA - Panama 1
PT - Portogallo 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 7.998
Città #
Warsaw 2.436
Fairfield 549
Woodbridge 325
Houston 295
Jacksonville 282
Ashburn 278
Chandler 235
Cambridge 221
Seattle 209
Wilmington 195
Ann Arbor 191
Hong Kong 147
Princeton 131
New York 102
Beijing 100
Dong Ket 87
Nanjing 83
Helsinki 76
Dublin 72
Brescia 67
Singapore 48
Jinan 39
Nanchang 37
Shanghai 33
Boardman 32
Dearborn 30
Des Moines 29
San Diego 29
Hebei 28
Shenyang 27
Changsha 25
Jiaxing 18
Tianjin 17
Phoenix 16
Brno 14
Lancaster 14
Milan 14
Parma 13
Zhengzhou 13
Haikou 12
Hangzhou 12
Munich 10
San Francisco 10
Verona 10
London 9
Guangzhou 8
Kilburn 8
Kunming 8
Lanzhou 8
Brussels 7
Los Angeles 7
Norwalk 7
Taiyuan 7
Ningbo 6
Toronto 6
Augusta 5
Fuzhou 5
Gunzenhausen 5
Leawood 5
San Mateo 5
Chicago 4
Hefei 4
Kocaeli 4
Lappeenranta 4
Orange 4
Taizhou 4
Canberra 3
Modena 3
Monmouth Junction 3
Olomouc 3
Padova 3
Ponte San Pietro 3
Sincan 3
Southwark 3
Udine 3
Amsterdam 2
Ardabil 2
Bergamo 2
Bloomington 2
Castiglione Delle Stiviere 2
Chiswick 2
Colombo 2
Falkenstein 2
Irmo 2
Marchiennes 2
New Bedfont 2
Prescot 2
Redwood City 2
Rezzato 2
Tappahannock 2
Villeurbanne 2
Wandsworth 2
Washington 2
Acton 1
Almaty 1
Amman 1
Baghdad 1
Baku 1
Berlin 1
Boston 1
Totale 6.811
Nome #
Bridging the past and the future of virology: Surface plasmon resonance as a powerful tool to investigate virus/host interactions. 270
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use 238
Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Epheephrin system 233
Biological role of immunoglobulin Free light chains interactomes 230
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 226
BSA conjugates bearing multiple copies of the basic domain of HIV-1 Tat: prototype for the development of multitarget inhibitors of extracellular Tat 224
Inhibition of Non Canonical HIV-1 Tat Secretion Through the Cellular Na+,K+-ATPase Blocks HIV-1 Infection 221
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 219
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 219
Speeding Up the Identification of Cystic Fibrosis Transmembrane Conductance Regulator-Targeted Drugs: An Approach Based on Bioinformatics Strategies and Surface Plasmon Resonance 217
Activation of Hsp90 Enzymatic Activity and Conformational Dynamics through Rationally Designed Allosteric Ligands 212
Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitors 212
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 203
Functionalization of gold surfaces with copoly(DMA-NAS-MAPS) by dip coating: Surface characterization and hybridization tests 203
The AGMA1 poly(amidoamine) inhibits the infectivity of herpes simplex virus in cell lines, in human cervicovaginal histocultures, and in vaginally infected mice 199
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 196
Membrane association of peroxiredoxin-2 in red cells is mediated by n-terminal cytoplasmic domain of band 3 184
The agmatine-containing poly(Amidoamine) polymer AGMA1 binds cell surface heparan sulfates and prevents attachment of mucosal human papillomaviruses 179
Pradamicin A: a new therapeutic concept for tretment of virus infections with a glycosilated envelope such as human immunodeficiency virus 178
A complex of α(6) integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6. 172
Chemoselective surface immbolization of proteins through a cleavable peptide 160
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 158
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of HIV-1 Tat and gp120 proteins 152
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an anti-angiogenic multi-target fibroblast growth factor-2 antagonist. 136
A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activity 116
Merging colloidal nanoplasmonics and surface plasmon resonance spectroscopy for enhanced profiling of multiple myeloma-derived exosomes 116
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 113
Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy 112
Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17 111
HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation 107
Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children 106
Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis 104
HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2 98
Angiostatic, tumor inflammatory and anti-tumor effects of CXCL4(47-70) and CXCL4L1(47-70) in an EGF-dependent breast cancer model. 97
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 97
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2) 95
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity 93
Direct and Allosteric Inhibition of the FGF2/HSPGs/FGFR1 Ternary Complex Formation by an Antiangiogenic, Thrombospondin-1-Mimic Small Molecule. 92
Peptide-Derivatized SB105-A10 Dendrimer Inhibits the Infectivity of R5 and X4 HIV-1 Strains in Primary PBMCs and Cervicovaginal Histocultures 92
Positively charged peptides can interact with each other as revealed by solid phase binding assays 90
Surface plasmon resonance analysis of heparin-binding angiogenic growth factors 87
Sulfated K5 Escherichia coli polysaccharide derivatives as wide range inhibitors of genital types of human papillomavirus 86
Identification of a dendrimeric heparan sulfate-binding peptide that inhibits infectivity of genital types of human papillomaviruses 84
Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding Peptide. 82
Plasmonic exosomes for enhanced monitoring of monoclonal gammopathies 78
A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual 74
alpha v beta 3 integrin-dependent activation of focal adhesion kinase mediates NF-kB activation and motogenic activity by HIV-1 Tat in endothelial cells 72
endothelial cell adhesion to HIV-1 Tat: cross talk between integrin alphav beta3 and vascular endothelial growth factor receptor-2 (KDR) 66
Angiogenic growth factor-endothelial cell interaction: receptor binding and cell internalization techniques 64
The synthetic dipeptide pidotimod shows a chemokine-like activity through cxc chemokine receptor 3 (Cxcr3) 63
FGF2-Antagonist activity of long pentraxin-3 related peptides 62
FGF2- Antagonist activity of long pentraxin-3 58
Methotrexate inhibits SARS-CoV-2 virus replication “in vitro” 56
EXPLOTING SURFACE PLASMON RESONANCE (SPR) TECHNOLOGY FOR THE IDENTIFICATION OF FIBROBLAST GROWTH FACTOR-2 (FGF2) ANTAGONISTS ENDOWED WITH ANTI-ANGIOGENIC ACTIVITY 52
Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin 52
Role of autophagy in von willebrand factor secretion by endothelial cells and in the in vivo thrombin-antithrombin complex formation promoted by the hiv-1 matrix protein p17 51
Identification of an anti-angiogenic FGF2-binding site in the n-terminal extension of the soluble pattern recognition receptor long-pentraxin PTX3 50
inhibition of intra- and extra-cellular Tat function and HIV expression by pertussin toxin B-oligomer 49
The NLS of the HIV-1 Tat protein interacts with the fd bacteriophage and with a peptide derived from its p8 protein 49
B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation 48
exploiting surface plasmon resonance technology for the identification of fibroblast growth factor 2 (FGF2) antagonists endowed with antiangiogenic activity 47
development of novel small molecules mimicking thrombospondin-1 (TSP-1) antiangiogenic activity 47
Avian Reovirus P17 Suppresses Angiogenesis by Promoting DPP4 Secretion 46
Human Metapneumovirus Establishes Persistent Infection in Lung Microvascular Endothelial Cells and Primes a Th2-Skewed Immune Response 38
Binding to PI(4,5)P2 is indispensable for secretion of B-cell clonogenic HIV-1 matrix protein p17 variants 35
Temporal viral loads in respiratory and gastrointestinal tract and serum antibody responses during SARS-CoV-2 infection in an Italian pediatric cohort 32
Sars-cov-2 infection remodels the phenotype and promotes angiogenesis of primary human lung endothelial cells 27
HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwide 24
Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host 22
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants 16
SARS-CoV-2 Infects Human ACE2-Negative Endothelial Cells through an αvβ3 Integrin-Mediated Endocytosis Even in the Presence of Vaccine-Elicited Neutralizing Antibodies 14
Emergence of S gene-based quasispecies explains an optimal adaptation of Omicron BA.5 subvariant in the immunocompetent vaccinated human host 12
The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5 Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung Microvascular Endothelial Cells 11
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action 10
Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions 5
Totale 8.149
Categoria #
all - tutte 30.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.770


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.423 239 143 135 224 184 253 211 239 197 331 130 137
2020/20211.586 59 144 63 200 87 166 118 202 155 155 114 123
2021/2022627 37 147 15 18 16 15 32 46 33 72 59 137
2022/2023565 75 30 22 35 52 136 2 77 85 3 28 20
2023/2024699 44 10 61 39 42 116 31 27 152 28 31 118
2024/202513 13 0 0 0 0 0 0 0 0 0 0 0
Totale 8.149